Drug profile · INN
iodohippurate sodium i-123
NEPHROFLOW
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
iodohippurate sodium i-123 (NEPHROFLOW) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN iodohippurate sodium i-123
Brand NEPHROFLOW
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is iodohippurate sodium i-123?
iodohippurate sodium i-123 (NEPHROFLOW) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for iodohippurate sodium i-123?
NEPHROFLOW is a marketed brand name for iodohippurate sodium i-123. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iodohippurate sodium i-123?
iodohippurate sodium i-123 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.